Equities

Qrons Inc

QRON:QBB

Qrons Inc

Actions
  • Price (USD)0.1855
  • Today's Change0.00 / 0.00%
  • Shares traded-1.00
  • 1 Year change-53.63%
  • Beta0.7339
Data delayed at least 15 minutes, as of Mar 08 2024.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

Qrons Inc. is a biotechnology company. The Company is focuses on developing biotech products, treatments, and technologies to combat neuronal and infectious diseases with a focus on antibiotic resistant bacteria. It has developed a treatment that integrates proprietary, engineered mesenchymal stem cells (MSCs), 3D printable implant, smart materials, and a novel delivery system. The Company has developed two product candidates for treating penetrating and non-penetrating (concussion-like) traumatic brain injuries (TBIs), both integrating proprietary, anti-brain inflammation synthetic hydrogel and modified MSCs. QS100TM is an injury specific, 3D printable, implantable MSCs-synthetic hydrogel, to treat penetrating brain injuries and QS200TM is an injectable MSCs-synthetic hydrogel for the treatment of diffused injuries commonly referred to as concussions. The Company researches in the fields of regenerative medicine, tissue engineering and 3D printable hydrogels.

  • Revenue in USD (TTM)0.00
  • Net income in USD-789.36k
  • Incorporated2016
  • Employees2.00
  • Location
    Qrons Inc28-10 JACKSON AVENUE, #26NLONG ISLAND CITY 11101United StatesUSA
  • Phone+1 (212) 945-2080
  • Websitehttps://qrons.com/
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
Galmed Pharmaceuticals Ltd0.00-6.91m2.43m3.00--0.1472-----3.68-3.680.002.750.00----0.00-41.65-45.06-50.55-50.79------------0.00------61.31------
Aoxing Pharmaceutical Company Inc30.11m-1.46m2.46m339.00--0.0287--0.0816-0.0192-0.01920.39510.25070.4962.322.56---2.41-14.54-7.06-35.4576.1968.51-4.85-37.690.73680.33870.6052--26.8837.20-62.49---38.80--
SYBLEU Inc11.70k-307.88k2.46m--------210.27-0.0293-0.02930.0011-0.03670.0641-------168.63-----------2,631.45-----8.484.96--0.00--26.51------
InMed Pharmaceuticals Inc5.63m-6.08m2.46m13.00--0.1685--0.4381-1.23-1.230.92841.750.40062.7129.77---43.26-88.10-50.03-104.1939.20---108.01-1,066.115.80--0.00--279.60--57.27--29.56--
Applied DNA Sciences Inc5.52m-12.50m2.47m53.00------0.4479-17.13-17.137.67-0.05580.389310.384.64104,110.80-87.15-88.57-111.09-121.9133.9844.35-223.89-113.261.54-------26.4327.92-18.73--33.80--
Gamida Cell Ltd1.78m-63.00m2.53m145.00------1.42-0.6582-0.65820.0162-0.02040.0157----12,303.45-55.51-56.15-71.23-67.6218.50---3,531.17-18,390.582.09--1.04------20.63---8.05--
Qrons Inc0.00-789.36k2.53m2.00---------0.0581-0.05810.00-0.1090.00----0.00-45,235.53-1,513.45---------------5.76---------7.61------
Aridis Pharmaceuticals Inc22.36m-1.14m2.56m37.00------0.1144-0.1845-0.18450.7074-0.26482.40--58.45604,297.30-12.24-120.16---678.29-----5.11-1,559.63--------101.3729.1634.43---34.84--
CNS Pharmaceuticals Inc0.00-17.46m2.57m3.00---------3.58-3.580.00-0.41530.00----0.00-384.86-132.47---185.75---------------------23.42------
Lucy Scientific Discovery Inc16.73k-9.76m2.58m----31.74--154.01-6.34-7.210.01030.0460.0037--0.7276---215.45------49.97---58,360.55-----5.100.4615-------53.49------
DSwiss Inc1.47m-49.54k2.59m11.00--45.84157.511.76-0.0002-0.00020.00710.00033.92154.8254.81133,643.60-13.22-8.69-50.26-45.4724.4425.55-3.37-2.471.05-15.740.3961---20.5046.20-688.36---66.17--
Agile Therapeutics Inc21.50m-7.79m2.59m19.00------0.1205-3.65-3.656.98-1.511.632.905.421,131,316.00-59.25-94.24---142.6259.73---36.26-513.500.3843------80.02--43.08------
Navidea Biopharmaceuticals Inc610.00-8.81m2.60m11.00------4,265.89-0.2086-0.05470.00001-0.03270.00010.15290.006655.45-143.97-169.68---753.52-8,103.2891.34-1,411,062.00-1,938.530.5066-------87.65-48.49-46.75--63.23--
Windtree Therapeutics Inc0.00-20.29m2.66m15.00--7.94-----8.21-8.210.000.56550.00----0.00-57.68-44.51-63.50-48.38-------94,533.34----0.8179------48.25------
AgriFORCE Growing Systems Ltd16.28k-11.73m2.69m7.00--0.0705--165.21-14.14-14.140.0141.470.0008--0.4082,325.71-59.84-78.95-84.37-109.8616.58---72,071.25-243,182.500.6922-1.390.3253------8.85--48.61--
Data as of Mar 08 2024. Currency figures normalised to Qrons Inc's reporting currency: US Dollar USD
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.